Sheryl Abrams
Acute Care · Langhorne, PANPI 1609115831
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 130 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 21.3% — the pattern of someone who eats at a lot of different presentations. Among acute care clinicians in PA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 130 payments — averaging $25.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$699
- Impulse Dynamics (USA) Inc.$377
- AstraZeneca$366
- Novo Nordisk$291
- Kestra Medical Technology Services, Inc.$239
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$214
- plus $1K from 19 others
What the payments were for
- Food & beverage$3,280100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 22 | $699 |
| Impulse Dynamics (USA) Inc. | 10 | $377 |
| AstraZeneca | 15 | $366 |
| Novo Nordisk | 12 | $291 |
| Kestra Medical Technology Services, Inc. | 6 | $239 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 13 | $214 |
| Amgen | 8 | $149 |
| Pfizer | 8 | $149 |
| United Therapeutics Corporation | 1 | $125 |
| Amarin Pharma, Inc. | 7 | $99 |
| E.r. Squibb & Sons, L.L.C. | 5 | $94 |
| Merck | 4 | $83 |
| Abbott | 2 | $47 |
| Astellas Pharma US Inc | 3 | $46 |
| Johnson & Johnson | 2 | $41 |
| Novartis | 2 | $40 |
| Esperion Therapeutics, Inc. | 2 | $38 |
| Baxter Healthcare | 1 | $32 |
| Daiichi Sankyo Inc. | 1 | $27 |
| Abiomed | 1 | $26 |
| Lexicon Pharmaceuticals, Inc. | 1 | $23 |
| Sanofi-aventis U.S. LLC | 1 | $22 |
| Regeneron Healthcare Solutions, Inc. | 1 | $22 |
| Inari Medical, Inc. | 1 | $17 |
| Bayer | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- WATCHMAN Access System$217
- FASENRA$118
- Wegovy$117
How this compares
$3,280 in reported general payments places this provider in the 90th percentile of 872 acute care providers in Pennsylvania.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 18 | $19,121 |
| FarxigaDapagliflozin Propanediol | 14 | $7,550 |
| ClopidogrelClopidogrel Bisulfate | 63 | $695 |
| Atorvastatin Calcium | 37 | $404 |
| Rosuvastatin Calcium | 16 | $204 |
| Carvedilol | 14 | $182 |
| Pantoprazole Sodium | 26 | $138 |
| Metoprolol Succinate | 15 | $116 |
| Amlodipine Besylate | 19 | $70 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 12 | $66 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $149 | $19,12118 claims |
| AstraZenecaFarxiga | $366 | $7,55014 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 872 acute care providers in Pennsylvania.
Other acute care in Langhorne
- Michelle MulderigLanghorne$3K
- Kristi MontrellaAltoona$111K
- Kathryn GreenPhiladelphia$92K
- Caroline PratzPhiladelphia$77K
- Donna KinzlerPittsburgh$25K
- Lisa JohnsonPottstown$25K
- Kathryn McParlaneMoon Township$21K
- Rebecca MarcantuonoPhiladelphia$17K
- Stephanie TothPhiladelphia$17K
- Kevin HaganAbington$17K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.